SAN DIEGO, Nov. 19, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide ...
SAN DIEGO - Avidity Biosciences, Inc. (NASDAQ:RNA) announced Wednesday the establishment of a Managed Access Program (MAP) for delpacibart zotadirsen (del-zota), its investigational therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback